Long-term outcomes in survivors of neuroblastoma: A report from the childhood cancer survivor study

Journal of the National Cancer Institute

Volumn 101, Issue 16, 2009, Pages 1131-1140

  Laverdiére, Caroline ^a,i   Liu, Qi ^b   Yasui, Yutaka ^b   Nathan, Paul C ^c   Gurney, James G ^d   Stovall, Marilyn ^e   Diller, Lisa R ^f   Cheung, Nai Kong ^g   Wolden, Suzanne ^g   Robison, Leslie L ^h   Sklar, Charles A ^g  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

ⁱ UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GROWTH HORMONE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLINDNESS; BRAIN TUMOR; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVOR; CATARACT; CHILD; CHILDHOOD CANCER; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG EXPOSURE; EMPLOYMENT STATUS; FEMALE; GROWTH HORMONE DEFICIENCY; HEARING LOSS; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; INCIDENCE; INCOME; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MUSCULOSKELETAL DISEASE; NEUROBLASTOMA; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; OVARY INSUFFICIENCY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SECOND CANCER; SEX DIFFERENCE; SIBLING; SOCIAL ASPECT; SOFT TISSUE SARCOMA; SURVIVAL RATE; SURVIVAL TIME; THYROID CANCER; UNITED STATES;

ADOLESCENT; ADULT; CANADA; CHILD; CHRONIC DISEASE; FEMALE; HEALTH STATUS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; NEUROBLASTOMA; ODDS RATIO; QUALITY OF LIFE; SIBLINGS; SURVIVORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 69249105289     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp230     Document Type: Article

References (43)

1. Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute, Division of Cancer Prevention and Control, Surveillance Program, Cancer Statistics Branch, registry data 1975-2000. www. seer. cancer. gov. Accessed September 15, 2008.
2. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369(9579):2106-2120.
3. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999;341(16):1165-1173.
4. Oeffi nger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572- 1582.
5. Zebrack BJ, Zevon MA, Turk N, et al. Psychological distress in long-term survivors of solid tumors diagnosed in childhood: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2007;49(1):47-51.
6. Zeltzer LK, Recklitis C, Buchbinder D, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study [published online ahead of print on March 2, 2009]. J Clin Oncol. 2009;27(14):2396-2404.
7. Kajanti M. Neuroblastoma in 88 children: clinical features, prognostic factors, results and late effects of therapy. Ann Clin Res. 1983;15 :( suppl 39):1-68.
8. Paulino AC, Mayr NA, Simon JH, Buatti JM. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity. Int J Radiat Oncol Biol Phys. 2002;52(4):1025-1031.
9. Laverdiere C, Cheung NK, Kushner BH, et al. Long-term complications in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer. 2005;45(3):324-332.
10. Flandin I, Hartmann O, Michon J, et al. Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society. Int J Radiat Oncol Biol Phys. 2006;64(5):1424-1431.
11. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapaneinen P. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Bone Marrow Transplant. 1999;24(10):1131-1136.
12. Van Santen, de Kraker J, Vulsma T. Endocrine late effects from multimodality treatment of neuroblastoma. Eur J Cancer. 2005;41(12):1767-1774.
13. Trahair TN, Vowels MR, Johnston K, et al. Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation. Bone Marrow Transplant. 2007;40(8):741-746.
14. Parsons SK, Neault MW, Lehmann LE, et al. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant. 1998;22(7):669-674.
15. Kushner BH, Budnick A, Kramer K, Modak S, Cheung NK. Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer. 2006;107(2):417-422.
16. Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group. Pediatrics. 2007;120(5):1229-1236.
17. Kushner BH, Cheung NK, Kramer K, Heller G, Jhanwar SC. Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review. J Clin Oncol. 1998;16(12):3880-3889.
18. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38(4):229-239.
19. Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research [published online ahead of print April 13, 2009]. J Cin Oncol. 2009;27(14):2308-2318.
20. Leisenring WM, Mertens AC, Armstrong GT, et al. Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study [published online ahead of print April 13, 2009]. J Clin Oncol. 2009;27(14):2319-2327.
21. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987;317(10):588-593.
22. Mertens AC, Walls RS, Taylor L, et al. Characteristics of childhood cancer survivors predicted their successful tracing. J Clin Epidemiol. 2004;57(9):933-944.
23. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, FL:Chapman & Hall/CRC;1993.
24. Mertens AC, Liu Q, Neglia JP, et al. Cause-specifi c late mortality among 5-year survivors of childhood cancer. J Natl Cancer Inst. 2008;100:1-12.
25. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. 2. The Design and Analysis of Cohort Studies (IARC Scientifi c Publications No. 82). Lyon, France:International Agency for Research on Cancer;1987.
26. Gooley TA, Leisenring W, Crowley J, Storer JE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706.
27. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290(12):1583-1592.
28. Chemaitilly W, Merterns AC, Mitby P, Whitton J, Stovall M, Yasui Y. Acute ovarian failure in the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2006;91(5):1723-1728.
29. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
30. Mertens AC, Yasui Y, Neglia J, et al. Late mortality experience in fi ve-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001;19(13):3163-3172.
31. Möller TR, Garwicz S, Perfekt R, et al. Late mortality among fi ve-year survivors of cancer in childhood and adolescence. Acta Oncol. 2004;43(8):711-718.
32. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in fi ve-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst. 2001;93(8):618-629.
33. Rubino C, Adjadj E, Guerin S, et al. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. Int J Cancer. 2003;107(5):791-796.
34. Fleitz JM, Wootton-Gorges SL, Wyatt-Ashmead J, et al. Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood. Pediatr Radiol. 2003;33(8):540-545.
35. Argani P, Lae M, Ballard ET, et al. Translocation carcinomas of kidney after chemotherapy in childhood. J Clin Oncol. 2006;24(10):1529-1534.
36. Altinok G, Kattar MM, Mohamed A, Poulik J, Grignon D, Rabah R. Pediatric renal cell carcinoma associated with Xp 11.2 translocations/ TFE3 gene fusions and clinicopathologic associations. Pediatr Dev Pathol. 2005;8(2):168-180.
37. Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may infl uence academic and social development. J Clin Oncol. 2005;23(34):8588-8596.
38. Barrera M, Shaw AK, Speechley KN, Maunsell E, Pogany L. Educational and social late effects of childhood cancer and related clinical, personal and familial characteristics. Cancer. 2005;104(8):1751-1760.
39. Nathan PC, Ness KK, Greenberg M, et al. Health-related quality of life in adult survivors of childhood Wilms tumor or Neuroblastoma: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2007;49(5):704-715.
40. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297:2705-2715.
41. Möller TR, Garwicz S, Barlow L, et al. Decreasing late mortality among fi ve-year survivors of cancer in childhood and adolescence. J Clin Oncol. 2001;19:3173-3181.
42. Oeffi nger KC, Robison LL. Childhood cancer survivors, late effects, and a new model for understanding survivorship. JAMA. 2007;297:2762-2764.
43. Simone JV. Late mortality in childhood cancer: two excellent studies bring good news tempered by room for improvement. J Clin Oncol. 2001;19:3161-3162.